OPTIONS for a regulatory response to opioid use and misuse in Australia are being canvassed in a new discussion paper released by the Therapeutic Goods Administration on Fri.
The TGA noted that several overseas jurisdictions are already facing 'crises' in the widespread misuse of prescribed opioids, "and evidence shows Australia trending down a similar path".
The paper proposes a range of responses including smaller pack sizes for S8 opioids, a review of indications, restriction of high dose products to authority prescribing, strengthening risk management plans, label information reviews, raising awareness of alternatives and more - see tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Jan 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Jan 18
